CORVALGAN Itália - italiano - AIFA (Agenzia Italiana del Farmaco)

corvalgan

therabel pharma n.v. - molsidomina - molsidomina

SIDOMOL Itália - italiano - AIFA (Agenzia Italiana del Farmaco)

sidomol

therabel pharma n.v. - molsidomina - molsidomina

Corvaton Compresse Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

corvaton compresse

cps cito pharma services gmbh - molsidominum - compresse - molsidominum 2 mg, lactosum monohydricum 130 mg, crospovidonum, magnesii stearas, macrogolum 6000, pro compresso. - koronare herzkrankheit - synthetika

Corvaton forte Compresse Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

corvaton forte compresse

cps cito pharma services gmbh - molsidominum - compresse - molsidominum 4 mg, lactosum monohydricum 260 mg, crospovidonum, magnesii stearas, macrogolum 6000, pro compresso. - koronare herzkrankheit - synthetika

Corvaton retard Retardtabletten Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

corvaton retard retardtabletten

cps cito pharma services gmbh - molsidominum - retardtabletten - molsidominum 8 mg, lactosum monohydricum 106 mg, cellulosum microcristallinum, magnesii stearas, macrogolum 6000, ricini oleum hydrogenatum, pro compresso. - koronare herzkrankheit - synthetika

Corgeom 16 mg Retardtabletten Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

corgeom 16 mg retardtabletten

drac ag - molsidominum - retardtabletten - molsidominum 16 mg, hypromellosum, lactosum monohydricum 71.775 mg, glyceroli dibehenas, mannitolum, povidonum k 29-32, magnesii stearas, silica colloidalis anhydrica, e 172 (flavum), pro compresso obducto. - la malattia coronarica - synthetika

Thalidomide BMS (previously Thalidomide Celgene) União Europeia - italiano - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - talidomide - mieloma multiplo - immunosoppressori - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.